Escherichia coli bacteriophage Esc-COP-7 and pathogenic Escherichia coli proliferation inhibition application thereof

A technology of esc-cop-7 and Escherichia coli, which is applied in the direction of phage, virus/phage, medical raw materials derived from virus/phage, etc., to achieve high specificity effect

Active Publication Date: 2018-06-19
INTRON BIOTECHNOLOGY INC
View PDF2 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, after 2000, the limitations of existing antibiotics w

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Escherichia coli bacteriophage Esc-COP-7 and pathogenic Escherichia coli proliferation inhibition application thereof
  • Escherichia coli bacteriophage Esc-COP-7 and pathogenic Escherichia coli proliferation inhibition application thereof
  • Escherichia coli bacteriophage Esc-COP-7 and pathogenic Escherichia coli proliferation inhibition application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Example 1: Isolation of phages that can kill Escherichia coli

[0035] When isolating bacteriophages capable of killing Escherichia coli, samples secured from natural environments were used. In addition, Escherichia coli used for phage isolation has been previously isolated by the present inventors and identified as pathogenic Escherichia coli.

[0036] Next, the isolation procedure of the phage will be described in detail. Inoculate the TSB (Tryptic Soy Broth) medium (casein digest, 17g / L; soybean digest, 3g / L; glucose, 2.5g / L; NaCl, 5g / L; Dipotassium hydrogen phosphate, 2.5g / L) was added together with the collected sample (sample), and then cultured with shaking at 37°C for 3-4 hours. After culturing, centrifugation was performed at 8,000 rpm for 20 minutes, and the supernatant was recovered. Escherichia coli was inoculated into the recovered supernatant at a ratio of 1 / 1000, and then cultured again with shaking at 37° C. for 3-4 hours. In the case that the phag...

Embodiment 2

[0041] Embodiment 2: Genome isolation and sequence analysis of phage Esc-COP-7

[0042] The genome of phage Esc-COP-7 was isolated as follows. The genome was isolated using the phage suspension obtained in the same manner as in Example 1. First, in order to remove DNA and RNA of Escherichia coli that may be contained in the suspension, the 200 U of DNase I and RNase A were added to the phage suspension, and then placed at 37° C. for 30 minutes. After standing for 30 minutes, in order to eliminate the activity of DNase I and RNase A, 500 μl of 0.5M ethylenediaminetetraacetic acid (EDTA) was added, and then left still for 10 minutes. Then, it was left still at 65° C. for 10 minutes. Next, to disrupt the outer wall of the phage, add proteinase K After 100 μl, it was reacted at 37° C. for 20 minutes. Then, 500 μl of 10% sodium dodecylsulfate (SDS) was added, and then allowed to react at 65° C. for 1 hour. After reacting for 1 hour, add According to the composition rati...

Embodiment 3

[0046] Embodiment 3: the investigation of the ability of phage Esc-COP-7 to kill pathogenic escherichia coli

[0047] The ability of the isolated phage Esc-COP-7 to kill pathogenic Escherichia coli was investigated. The killing ability investigation was carried out by investigating whether or not a transparent ring was formed by the spot test proposed in Example 1. The pathogenic Escherichia coli used for the investigation of killing ability was isolated and identified as pathogenic Escherichia coli by the present inventors, and a total of 10 strains were used. Phage Esc-COP-7 has the ability to kill a total of 9 strains of the 10 strains of pathogenic Escherichia coli that became the subject of the experiment. Representative experimental results are as follows: figure 2 shown. In addition, the effect of phage Esc-COP-7 on Bordetella bronchiseptica, Enterococcus faecalis, Enterococcus faecium, Streptococcus mitis, Streptococcus uberis ( Streptococcus uberis) and Pseudomo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to myoviridae bacteriophage Esc-COP-7 (commissioned number: KCTC 13130BP) separated from the nature. The Esc-COP-7 is characterized by carrying a genome which has specific Escherichia coli killing capacity and is marked with a serial number 1. The invention also relates to a method for preventing and treating pathogenic Escherichia coli infection by use of composition containing the bacteriophage as an effective component.

Description

technical field [0001] The invention relates to a method for isolating bacteriophage capable of infecting and killing Escherichia coli from natural environment and using a composition containing the phage as an active ingredient to prevent and treat pathogenic Escherichia coli infection. Specifically, it relates to a Myoviridae phage Esc-COP-7 (trustee number: KCTC 13130BP) isolated from nature, which is characterized by carrying a genome marked with sequence number 1 and having the ability to specifically kill Escherichia coli and A method for preventing infection of pathogenic Escherichia coli and post-infection treatment using a composition containing the phage as an active ingredient. Background technique [0002] Escherichia coli belongs to the family Enterobacteriaceae, and most of them decompose lactose as Gram-negative bacilli, catalase-positive, oxidase-negative, facultative anaerobic bacteria. Escherichia coli is serologically classified into cell body (O), flagel...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N7/00A61K35/76A61P31/04
CPCA61K35/76C12N7/00C12N2795/10121C12N2795/10131Y02A50/30
Inventor 尹成俊全秀娟白亨琭孙志洙姜尚铉
Owner INTRON BIOTECHNOLOGY INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products